Esperion Therapeutics
ESPR
ESPR
136 hedge funds and large institutions have $352M invested in Esperion Therapeutics in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 42 increasing their positions, 42 reducing their positions, and 18 closing their positions.
Holders
136
Holders Change
+4
Holders Change %
+3.03%
% of All Funds
2.3%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
24
Increased
42
Reduced
42
Closed
18
Calls
$14.4M
Puts
$2.78M
Net Calls
+$11.6M
Net Calls Change
+$5.74M
Top Buyers
1 |
IC
1
Ikarian Capital
Dallas,
Texas
|
$13.1M |
2 |
2
Millennium Management
New York
|
$17.2M |
3 |
3
Point72 Asset Management
Stamford,
Connecticut
|
$6.76M |
4 |
WP
4
Woodline Partners
San Francisco,
California
|
$5.37M |
5 |
5
BlackRock
New York
|
$27.3M |